首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Covalently antibacterial alginate-chitosan hydrogel dressing integrated gelatin microspheres containing tetracycline hydrochloride for wound healing
【24h】

Covalently antibacterial alginate-chitosan hydrogel dressing integrated gelatin microspheres containing tetracycline hydrochloride for wound healing

机译:共价抗菌藻酸盐 - 壳聚糖水凝胶敷料含有盐酸四环素盐酸四环素愈合的综合明胶微球

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

An antibacterial and biodegradable composite hydrogel dressing integrated with microspheres is developed for drug delivery and wound healing. The mechanism of gelation is attributed to the Schiff-base reaction between aldehyde and amino groups of oxidized alginate (OAlg) and carboxymethyl chitosan (CMCS). To enhance antibacterial and mechanical properties, tetracycline hydrochloride (TH) loaded gelatin microspheres (GMs) were fabricated by an emulsion cross-linking method, followed by integrating into the OAlg-CMCS hydrogel to produce a composite gel dressing. In vitro gelation time, swelling, degradation, compressive modulus and rheological properties of the gel dressing were investigated as the function of microsphere ratios. With increasing ratios of microspheres from 10 to 40 mg/mL, the composite dressing manifested shorter gelation time and lower swelling ratios, as well as higher mechanical strength. Comparing to other formulations, the gel dressing with 30 mg/mL microspheres showed more suitable stabilities and mechanical properties for wound healing. Also, in vitro drug release results showed that the loaded TH could be sustained release from the composite gel dressing by contrast with pure hydrogels and microspheres. Furthermore, powerful bacteria growth inhibition effects against Escherichia coli and Staphylococcus aureus suggested that the composite gel dressing, especially the one with 30 mg/mL GMs containing TH, has a promising future in treatment of bacterial infection. (C) 2016 Elsevier B.V. All rights reserved.
机译:为药物递送和伤口愈合而开发了与微球一体化的抗菌和可生物降解的复合水凝胶敷料。凝胶化机制归因于氧化藻酸盐(OALG)和羧甲基壳聚糖(CMC)之间的醛和氨基之间的辛基碱反应。为了增强抗菌和机械性能,通过乳液交联方法制造盐酸盐酸盐盐(Th)盐酸盐盐(Th)盐酸盐素微球(GMS),然后将进入OALG-CMCS水凝胶中的聚合物制成,以产生复合凝胶敷料。研究了凝胶敷料的体外凝胶时间,溶胀,降解,压缩模量和流变性质作为微球比率的函数。随着10至40mg / ml的微球比率的增加,复合敷料表现出较短的凝胶化时间和更低的溶胀比,以及更高的机械强度。与其他配方相比,具有30mg / mL微球的凝胶敷料显示出更合适的稳定性和机械性能的伤口愈合。而且,体外药物释放结果表明,通过与纯水凝胶和微球对比,可以从复合凝胶敷料中释放。此外,对大肠杆菌和金黄色葡萄球菌的强大细菌生长抑制效应表明复合凝胶敷料,尤其是含有30mg / mL GMS的含有30mg / ml的,具有有希望的未来治疗细菌感染。 (c)2016年Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号